Literature DB >> 8968234

VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia.

J C Cooper1, A M Sharkey, D S Charnock-Jones, C R Palmer, S K Smith.   

Abstract

OBJECTIVE: To measure the mRNA levels of vascular endothelial growth factor and its receptor in the placenta following delivery after uncomplicated pregnancy and after pregnancies complicated by pre-eclampsia.
SETTING: Rosie Maternity Hospital, Cambridge. MATERIAL: Placental biopsies were obtained following delivery by caesarean section in 23 cases of pregnancy presenting at a range of gestational ages with pre-eclampsia. These were compared with biopsies from 20 appropriately matched women with uncomplicated pregnancies. MAIN OUTCOME MEASURE: mRNA levels of vascular endothelial growth factor (VEGF) and its receptor the fins-like tyrosine kinase (flt), were quantified in total RNA isolated from placental biopsies using the RNAse protection assay. The amount of RNA was compared with that of the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH), used as a standard. Results were expressed as arbitrary optical density units of VEGF/GAPDH and flt/GAPDH.
RESULTS: In both control and pre-eclamptic women regression analysis showed that the level of mRNA encoding VEGF declined significantly with gestational age (P < 0.0001). However, levels of VEGF mRNA were significantly lower in the pre-eclamptic women compared with the control women (P < 0.023).
CONCLUSIONS: This study provides evidence of an abnormality of growth factor expression in the placenta during pregnancies complicated by pre-eclampsia. Such placentae exhibit deficient growth and differentiation of terminal villi and reduced fetal capillary branching and reduced levels of VEGF could well account for these morphometric changes. This finding provides a molecular explanation for this abnormal placental development and points to VEGF as a factor in the aetiology of pre-eclampsia and its complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968234     DOI: 10.1111/j.1471-0528.1996.tb09627.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  24 in total

1.  Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.

Authors:  I Caniggia; S Grisaru-Gravnosky; M Kuliszewsky; M Post; S J Lye
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

Review 2.  Role of placenta in preeclampsia.

Authors:  Leslie Myatt
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 3.  Placental angiogenesis in sheep models of compromised pregnancy.

Authors:  Lawrence P Reynolds; Pawel P Borowicz; Kimberly A Vonnahme; Mary Lynn Johnson; Anna T Grazul-Bilska; Dale A Redmer; Joel S Caton
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

Review 4.  Obesity "complements" preeclampsia.

Authors:  Kelsey N Olson; Leanne M Redman; Jenny L Sones
Journal:  Physiol Genomics       Date:  2019-02-04       Impact factor: 3.107

5.  Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia.

Authors:  Lauretta A Lacko; Micol Massimiani; Jenny L Sones; Romulo Hurtado; Silvia Salvi; Sergio Ferrazzani; Robin L Davisson; Luisa Campagnolo; Heidi Stuhlmann
Journal:  Mech Dev       Date:  2014-04-19       Impact factor: 1.882

Review 6.  VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer.

Authors:  P M Biselli-Chicote; A R C P Oliveira; E C Pavarino; E M Goloni-Bertollo
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-02       Impact factor: 4.553

7.  Vitamin D improves the angiogenic properties of endothelial progenitor cells.

Authors:  M Grundmann; M Haidar; S Placzko; R Niendorf; N Darashchonak; C A Hubel; F von Versen-Höynck
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-29       Impact factor: 4.249

8.  Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection.

Authors:  Ekaterina Maidji; Giovanni Nigro; Takako Tabata; Susan McDonagh; Naoki Nozawa; Stephen Shiboski; Stefania Muci; Maurizio M Anceschi; Natali Aziz; Stuart P Adler; Lenore Pereira
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

9.  Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.

Authors:  Jin-Young Chung; Yang Song; Yuping Wang; Ronald R Magness; Jing Zheng
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

10.  Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.

Authors:  Sarah N Cross; Elena Ratner; Thomas J Rutherford; Peter E Schwartz; Errol R Norwitz
Journal:  Rev Obstet Gynecol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.